Disposable Resuscitation Devices MarketSize, Share & Industry Analysis, 2026-2034By Product TypeBy TypeBy ApplicationBy End UserBy Distribution Channel

Disposable resuscitation devices are single-use airway and ventilation support products, including bag valve masks, anesthesia and CPR masks, oxygen delivery masks and nasal cannulas, and oral and nasal airway adjuncts, used to restore or support a patient's breathing during cardiac arrest, surgery, trauma or respiratory failure. They are designed for one-time use and disposal after a single patient encounter, reducing cross-contamination risk compared with devices that must be cleaned and reused. Buyers include hospitals, ambulatory surgical centers, emergency medical services and, to a lesser extent, home care providers, all of whom stock these devices for immediate use in emergency and routine clinical settings.

USD 1.29 billion of revenue was recorded in the global disposable resuscitation devices market in 2025. By 2034 the figure reaches USD 2.18 billion, a compound annual growth rate of 5.98% through the forecast period, along a series that runs USD 0.98 billion in 2020, USD 1.23 billion in 2024, USD 1.37 billion in 2026 and USD 1.73 billion in 2030.

Composition changes more than the total does. Airway Management Devices, at 10.28%, outgrows Disposable Anesthesia & CPR Masks at 4.7%, and its share moves from 11.6% to 16.1%. Manual Resuscitators (Bag Valve Mask) stays the largest line throughout, at USD 0.54 billion in 2025 and USD 0.9 billion in 2034. Share moves toward Airway Management Devices and away from Manual Resuscitators (Bag Valve Mask), Disposable Anesthesia & CPR Masks and Oxygen Delivery Masks & Nasal Cannulas, though no line shrinks in revenue terms.

The type split puts Adult first, at USD 1.01 billion and 78% of revenue in 2025, rising to USD 1.66 billion and 76% in 2034. Kid grows faster at 7.12% against 5.67%, moving from 22% of revenue to 24% by 2034. It cuts the same total as the product type axis from a different commercial angle, so revenue does not add across the two.

North America is the largest region at 34% of 2025 revenue, worth USD 0.44 billion and reaching USD 0.68 billion by 2034. Europe follows at 27%, moving from USD 0.35 billion to USD 0.55 billion, and Middle East and Africa is the smallest at 7%. Asia Pacific gain share across the period, so growth is not distributed evenly between regions.

Behind these figures sit five regions, four product type lines and five segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is a triangulation of published figures and category proxies rather than a directly sourced total, and the same applies to the segment, regional and country breakdowns drawn from it.

• A forecast-period rate of 5.98% takes the market from USD 1.29 billion in 2025 to USD 2.18 billion in 2034, against 5.65% recorded over the 2020-2025 historical period.
• 41.9% of 2025 revenue sits in Manual Resuscitators (Bag Valve Mask) (USD 0.54 billion) and it remains the largest product type line in 2034 at USD 0.9 billion and 41.3%.
• At 10.28%, Airway Management Devices grows faster than any other product type line, moving from USD 0.15 billion and 11.6% of revenue in 2025 to USD 0.35 billion and 16.1% in 2034.
• Against a base case of USD 2.18 billion in 2034, the study also reports a bear case at USD 1.92 billion and a bull case at USD 2.47 billion, with the assumptions behind each set out separately.
• 34% of 2025 revenue is generated in North America, worth USD 0.44 billion and rising to USD 0.68 billion by 2034; Middle East and Africa is smallest at 7%.
• Within North America, the United States is the worked country example, at USD 0.37 billion in 2025; 84.1% of regional revenue in the base year, and USD 0.58 billion by 2034.
• Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region rather than a single blended series.

Read across the forecast period, the global disposable resuscitation devices market shows movement in three places: product type composition, regional weight, and the 5.98% rate applied to the whole.

Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.

Airway Management Devices outpaces Disposable Anesthesia & CPR Masks. Airway Management Devices grows at 10.28% across 2026-2034 against 4.7% for Disposable Anesthesia & CPR Masks, the widest spread on the product type axis. By 2034 the two sit at 16.1% and 23.9% of revenue, against 11.6% and 26.4% in 2025. In absolute terms Airway Management Devices rises from USD 0.15 billion to USD 0.35 billion, while Disposable Anesthesia & CPR Masks rises from USD 0.34 billion to USD 0.52 billion. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.

Growth concentrates in Asia Pacific. Asia Pacific moves from 24% of revenue in 2025 to 29% in 2034, worth USD 0.31 billion rising to USD 0.63 billion. Share moves off the others in turn: North America at 34% moving to 31%, Europe at 27% moving to 25%, Latin America at 8% moving to 8%, Middle East and Africa at 7% moving to 7%, each still growing in revenue terms. That makes the regional split worth reading rather than scaling from the global rate: the same market rate produces different outcomes depending on where a supplier's revenue sits.

Growth compounds at 5.98% without a step change. Reading the series: USD 0.98 billion in 2020, USD 1.23 billion in 2024, USD 1.29 billion in 2025, USD 1.37 billion in 2026, USD 1.73 billion in 2030 and USD 2.18 billion in 2034. No year breaks the trajectory, and the 5.98% forecast rate compares with 5.65% recorded over 2020-2025, a continuation rather than an inflection. A plan built on this market is therefore a plan about capturing a share of steady expansion, which is decided on the product type and regional axes, not by the headline rate.

Airway Management Devices carries the market's growth rate

Three sources account for the growth to 2034: 5.98% compounding across the base, share moving toward the faster product type lines, and above-market expansion in the leading regions.

The bear case and what drives it

What the bull case turns on

One product type line carries the market

North America holds 34% of the global disposable resuscitation devices market in 2025, worth USD 0.44 billion rising to USD 0.68 billion in 2034. That makes it the first-largest region covered, in 2025 and again in 2034.

31% of global revenue sits here in 2034, below the 2025 level, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Segment composition follows the global pattern: Manual Resuscitators (Bag Valve Mask) largest at 41.9% of 2025 revenue, Airway Management Devices fastest at 10.28%. North America is reported axis by axis and country by country in the full study.

84.1% of North America's base-year revenue comes from the United States; USD 0.37 billion, rising to USD 0.58 billion by 2034. Carrying 84.1% of the region in the base year, it sets North America's direction rather than contributing to it. Set against USD 0.44 billion and USD 0.68 billion for the region, it is why this market rather than a smaller one is the one reported in full.

The product type pattern in the United States is the global one: 41.9% of 2025 revenue in Manual Resuscitators (Bag Valve Mask), 41.3% by 2034, against 10.28% growth in Airway Management Devices taking it from 11.6% to 16.1%. With 84.1% of North America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Per-product type revenue for the United States appears on its own in the full report.

In the United States, disposable resuscitation devices such as manual resuscitators and bag valve masks fall under the Food and Drug Administration's medical device framework, typically classified as Class II devices requiring premarket notification that demonstrates substantial equivalence to a legally marketed predicate. Manufacturers must operate under the FDA's Quality System Regulation, now harmonized with the international quality management standard for medical devices, and comply with labeling requirements covering intended use, single-use designation, and sterility status where applicable. Unique device identification and post-market reporting obligations also apply, supporting traceability and ongoing safety surveillance for devices used in emergency airway management.

The suppliers tracked in this study (Ambu A/S, Teleflex Medical, Intersurgical, WEINMANN, CareFusion Corporation, Smiths Medical, Bls System Limited, Bound Tree Medical, Aero Healthcare, Allied Healthcare Products Inc, Laerdal Medical Corp, Persys Medical, Vyaire Medical, Inc and O-Two Medical Technologies Inc) compete in the United States across the product type lines above. Two different problems sit on the same axis: holding Manual Resuscitators (Bag Valve Mask) at 41.9% of 2025 revenue, and taking Airway Management Devices while it grows at 10.28%. Country-level shares and positioning per company sit in the full report.

Within North America, Canada accounts for 15.9% of regional revenue and 5.4% of the global total, worth USD 0.07 billion in 2025 and USD 0.1 billion by 2034.

USD 0.35 billion of 2025 revenue is generated in Europe, 27% of the global disposable resuscitation devices market with USD 0.55 billion projected for 2034. That makes it the second-largest region covered, in 2025 and again in 2034.

Share settles at 25% in 2034, though revenue still rises throughout; what changes is the region's weight against faster-growing ones, which is not the same as weakening demand.

Within the region the product type split tracks the global one; 41.9% of 2025 revenue in Manual Resuscitators (Bag Valve Mask), fastest growth of 10.28% in Airway Management Devices. Europe is reported axis by axis and country by country in the full study.

The largest single market in Europe is Germany, at USD 0.11 billion in 2025 and USD 0.17 billion in 2034. At 31.4% of the region in 2025 it leads, but a majority of Europe's revenue is generated in other markets. Set against USD 0.35 billion and USD 0.55 billion for the region, it is why this market rather than a smaller one is the one reported in full.

Demand in Germany follows the product type mix reported at global level: Manual Resuscitators (Bag Valve Mask) is the largest line at 41.9% of 2025 revenue, moving to 41.3% by 2034, while Airway Management Devices grows fastest at 10.28% and takes its share from 11.6% to 16.1%. Because the country carries 31.4% of Europe, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. Germany carries its own product type breakdown in the full report.

In Germany, as elsewhere in the European Union, disposable resuscitation devices are regulated under the EU Medical Device Regulation, with national oversight from the Federal Institute for Drugs and Medical Devices. Manufacturers must classify the device according to its intended use and associated risk, compile technical documentation demonstrating conformity with the regulation's general safety and performance requirements, and, depending on classification, engage a notified body before affixing the CE mark. Conformity with harmonized European standards for anaesthetic and respiratory equipment is expected, alongside instructions for use and labelling in the local language, plus post-market surveillance and vigilance reporting once the device is placed on the market.

Ambu A/S, Teleflex Medical, Intersurgical, WEINMANN, CareFusion Corporation, Smiths Medical, Bls System Limited, Bound Tree Medical, Aero Healthcare, Allied Healthcare Products Inc, Laerdal Medical Corp, Persys Medical, Vyaire Medical, Inc and O-Two Medical Technologies Inc are the suppliers covered in Germany. Manual Resuscitators (Bag Valve Mask), at 41.9% of 2025 revenue, is where the volume sits, and Airway Management Devices, growing at 10.28%, is where position changes hands over the forecast period.

The United Kingdom is sized at USD 0.09 billion in 2025, rising to USD 0.14 billion by 2034; 7% of global revenue and 25.7% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

5.4% of global revenue is generated in France; USD 0.07 billion in 2025, reaching USD 0.11 billion in 2034, and 20% of Europe.

USD 0.31 billion of 2025 revenue is generated in Asia Pacific, 24% of the global disposable resuscitation devices market and reaches USD 0.63 billion by 2034. That makes it the third-largest region covered, in 2025 and again in 2034.

Share climbs to 29% by 2034, at a pace above the 5.98% global rate, which is what makes this region worth reading separately rather than scaling from the total.

Within the region the product type split tracks the global one; 41.9% of 2025 revenue in Manual Resuscitators (Bag Valve Mask), fastest growth of 10.28% in Airway Management Devices. Revenue for Asia Pacific is broken out by every segmentation axis and by country in the full report.

China is the largest market within Asia Pacific, generating USD 0.12 billion in 2025 and projected to reach USD 0.24 billion by 2034. At 38.7% of the region in 2025 it leads, but a majority of Asia Pacific's revenue is generated in other markets. Against regional totals of USD 0.31 billion in 2025 and USD 0.63 billion in 2034, it is the country the full report breaks out in detail.

China buys along the same lines as the market globally; Manual Resuscitators (Bag Valve Mask) first at 41.9% of 2025 revenue and 41.3% in 2034, Airway Management Devices fastest at 10.28% on a share moving from 11.6% to 16.1%. Since 38.7% of Asia Pacific's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. The full report reports China by product type separately.

In China, disposable resuscitation devices are regulated by the National Medical Products Administration, which classifies medical devices by risk and requires registration before a product may be marketed, generally through a domestic agent or licensed local entity for imported devices. Applicants must submit technical and clinical evaluation data demonstrating safety and performance, along with evidence of conformity to applicable national standards for respiratory and anaesthesia equipment. Chinese-language labelling and instructions for use are mandatory, and manufacturing facilities are subject to quality management system requirements aligned with the country's own good manufacturing practice framework for medical devices, alongside post-market adverse event monitoring.

In China the field is Ambu A/S, Teleflex Medical, Intersurgical, WEINMANN, CareFusion Corporation, Smiths Medical, Bls System Limited, Bound Tree Medical, Aero Healthcare, Allied Healthcare Products Inc, Laerdal Medical Corp, Persys Medical, Vyaire Medical, Inc and O-Two Medical Technologies Inc. The commercially relevant division is 41.9% of 2025 revenue in Manual Resuscitators (Bag Valve Mask), where the volume is, against 10.28% growth in Airway Management Devices, where share moves.

5.4% of global revenue is generated in Japan; USD 0.07 billion in 2025, reaching USD 0.15 billion in 2034, and 22.6% of Asia Pacific.

3.9% of global revenue is generated in India; USD 0.05 billion in 2025, reaching USD 0.1 billion in 2034, and 16.1% of Asia Pacific.

8% of the global disposable resuscitation devices market sits in Latin America in 2025, worth USD 0.1 billion with USD 0.17 billion projected for 2034. It is a marginal region on this axis, fourth by revenue throughout the period.

By 2034 the share stands at 8%, though revenue still rises throughout; what changes is the region's weight against faster-growing ones, which is not the same as weakening demand.

Manual Resuscitators (Bag Valve Mask) leads here as it does globally, at 41.9% of 2025 revenue, and Airway Management Devices again grows fastest at 10.28%. The full report breaks Latin America out along every axis and by country.

Brazil is the largest market within Latin America, generating USD 0.06 billion in 2025 and projected to reach USD 0.09 billion by 2034. Carrying 60% of the region in the base year, it sets Latin America's direction rather than contributing to it. The region itself runs USD 0.1 billion to USD 0.17 billion over the same period, and this is the market carrying the country-level detail in the full report.

The product type pattern in Brazil is the global one: 41.9% of 2025 revenue in Manual Resuscitators (Bag Valve Mask), 41.3% by 2034, against 10.28% growth in Airway Management Devices taking it from 11.6% to 16.1%. With 60% of Latin America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Brazil by product type separately.

In Brazil, disposable resuscitation devices fall under the oversight of the National Health Surveillance Agency, which requires medical devices to be classified by risk and either registered or listed with the agency before commercial distribution. Depending on classification, manufacturers or their local registration holder must demonstrate conformity with applicable safety and performance standards and, for higher-risk categories, provide evidence of a compliant quality management system verified through the agency's own good manufacturing practice certification process. Portuguese-language labelling, instructions for use, and traceability information are required, and imported devices must be represented by a Brazil-based registration holder responsible for compliance and post-market vigilance reporting.

The suppliers tracked in this study (Ambu A/S, Teleflex Medical, Intersurgical, WEINMANN, CareFusion Corporation, Smiths Medical, Bls System Limited, Bound Tree Medical, Aero Healthcare, Allied Healthcare Products Inc, Laerdal Medical Corp, Persys Medical, Vyaire Medical, Inc and O-Two Medical Technologies Inc) compete in Brazil across the product type lines above. Two different problems sit on the same axis: holding Manual Resuscitators (Bag Valve Mask) at 41.9% of 2025 revenue, and taking Airway Management Devices while it grows at 10.28%.

Within Latin America, Mexico accounts for 30% of regional revenue and 2.3% of the global total, worth USD 0.03 billion in 2025 and USD 0.05 billion by 2034.

Middle East and Africa holds 7% of the global disposable resuscitation devices market in 2025, worth USD 0.09 billion and reaches USD 0.15 billion by 2034. It is a marginal region on this axis, fifth by revenue throughout the period.

7% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Within the region the product type split tracks the global one; 41.9% of 2025 revenue in Manual Resuscitators (Bag Valve Mask), fastest growth of 10.28% in Airway Management Devices. Middle East and Africa is reported axis by axis and country by country in the full study.

33.3% of Middle East and Africa's base-year revenue comes from Saudi Arabia; USD 0.03 billion, rising to USD 0.05 billion by 2034. 33.3% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 0.09 billion in 2025 and USD 0.15 billion in 2034, it is the country the full report breaks out in detail.

Demand in Saudi Arabia follows the product type mix reported at global level: Manual Resuscitators (Bag Valve Mask) is the largest line at 41.9% of 2025 revenue, moving to 41.3% by 2034, while Airway Management Devices grows fastest at 10.28% and takes its share from 11.6% to 16.1%. Its 33.3% weight in Middle East and Africa means those movements carry straight into the regional totals. Revenue by product type for Saudi Arabia is reported separately in the full report.

In Saudi Arabia, disposable resuscitation devices are regulated by the Saudi Food and Drug Authority under its medical devices framework, which requires risk-based classification and registration on the national medical devices database prior to marketing. Manufacturers based outside the Kingdom must appoint a local authorized representative to manage registration, Arabic and English labelling, and post-market obligations. Conformity is generally demonstrated through recognition of approvals already obtained from reference regulatory systems, alongside evidence that the device meets applicable international standards for anaesthetic and respiratory equipment. Ongoing vigilance reporting and market surveillance obligations continue once the device is available for clinical and emergency use.

The suppliers tracked in this study (Ambu A/S, Teleflex Medical, Intersurgical, WEINMANN, CareFusion Corporation, Smiths Medical, Bls System Limited, Bound Tree Medical, Aero Healthcare, Allied Healthcare Products Inc, Laerdal Medical Corp, Persys Medical, Vyaire Medical, Inc and O-Two Medical Technologies Inc) compete in Saudi Arabia across the product type lines above. Volume sits in Manual Resuscitators (Bag Valve Mask) at 41.9% of 2025 revenue; movement sits in Airway Management Devices at 10.28% growth.

1.6% of global revenue is generated in South Africa; USD 0.02 billion in 2025, reaching USD 0.03 billion in 2034, and 22.2% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Product Type, type, application, End User, Distribution Channel, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.